Walgreens names SVP pharmaceutical development, market access
DEERFIELD, Ill. Walgreens announced Thursday that Jeffrey Berkowitz, a former SVP at drug maker Merck, has joined the company.
Berkowitz will serve as Walgreens’ SVP pharmaceutical development and market access, responsible for the overall pharmacy contracting strategy for the company, both on the pharmaceutical manufacturing side and on the retail payer side, the drug store chain said. He will report to Walgreens’ pharmacy services president Kermit Crawford.
“As we continue our efforts to transform community pharmacy, Jeff will play a vital role in working with our partners in the pharmaceutical industry, and across the entire healthcare sector, to develop strategies in collaboration with our sales and services organization that will provide better adherence and clinical outcomes for patients,” Crawford said. “In addition, Jeff’s exceptional experience, expertise and track record of growth and success in the pharmaceutical industry will be important to further enhancing our pharmacy, health-and-wellness solutions.”
Prior to joining Walgreens, Berkowitz served as SVP global market access at Merck, part of the Merck global human health leadership team, responsible for all activity related to access, pricing, payer marketing, health outcomes and health technology assessments worldwide.
Subsequent offering period expires for Sun Pharma
MUMBAI, India Sun Pharmaceutical Industries’ subsequent offering period by one of its subsidiaries for all outstanding ordinary shares for drug maker Taro has expired, Sun Pharma said Wednesday.
Sun subsidiary Alkaloida Chemical Company Exclusive Group was informed that 29,382 ordinary shares of Taro had been tendered as of Tuesday. During the pendency of the subsequent offering period, no additional shares have been tendered. All tendered ordinary shares were accepted for payment.
Boo-boos be gone with Smith & Nephew’s No-Sting Skin-Prep spray
ST. PETERSBURG, Fla. Smith & Nephew has created a liquid film-forming dressing that dries in less than 30 seconds.
The company’s alcohol-free No-Sting Skin-Prep spray has a four-day wear time and leaves a clear, waterproof, breathable and conformable barrier that allows for visual assessment of the periwound area.
"Our new No-Sting Skin-Prep spray enhances patient comfort because it is conformable, protects the skin from incontinence and friction, and won’t irritate damaged skin," said Tom Dugan, president of the North American wound management divsion at Smith & Nephew. "For the caregiver, the fast-drying spray offers quick and easy application, and long-lasting products save time and money. No-Sting Skin-Prep spray can help protect vulnerable skin, reducing the risk of costly infections. The addition of No-Sting Skin-Prep spray to our liquid film-forming dressing line and our broad portfolio of trusted wound care brands reflects our commitment to providing solutions that promote positive patient outcomes and cost-effective patient care."